About the Company
We do not have any company description for iTeos Therapeutics, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on iTeos Therapeutics, Inc.
iTeos Therapeutics Announces Its Intention to Wind Down Operations
WATERTOWN, Mass. and GOSSELIES, Belgium, May 28, 2025 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development of a ...
iTeos Therapeutics Announces Appointment of David Feltquate as Chief ...
WATERTOWN, Mass. and GOSSELIES, Belgium, Aug. 05, 2024 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS) (“iTeos”), a clinical-stage biopharmaceutical company pioneering the ...
Strength Seen in iTeos Therapeutics, Inc. (ITOS): Can Its 7.4% Jump ...
iTeos Therapeutics, Inc. (ITOS) shares ended the last trading session 7.4% higher at $10.65. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the ...
iTeos Reports Topline Interim Results from GALAXIES Lung-201 Study of ...
WATERTOWN, Mass. and GOSSELIES, Belgium, May 13, 2025 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development of a ...
iTeos Therapeutics Announces Late-Breaking Oral Presentation of Phase 2 ...
The ESMO website indicates that all late-breaking abstracts will be published on the ESMO website on the day of the presentation at 00:05 am CEST. About iTeos Therapeutics, Inc.
iTeos Therapeutics, Inc. (ITOS) - Yahoo Finance
WATERTOWN, Mass. and GOSSELIES, Belgium, Aug. 20, 2024 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS) (“iTeos”), a clinical-stage biopharmaceutical company pioneering the discovery and ...
iTeos Therapeutics Enters into Agreement to Be Acquired by Concentra ...
Investor and Media Contact: Matthew Gall iTeos Therapeutics, Inc. matthew.gall@iteostherapeutics.com NOTE: This content is not written by or endorsed by "WCMH", its advertisers, or Nexstar Media Inc.
iTeos Therapeutics Inc.: iTeos Therapeutics Enters into Agreement to Be ...
About iTeos Therapeutics, Inc. iTeos Therapeutics is headquartered in Watertown, MA, with an office in Gosselies, Belgium. For more information please visit www.iteostherapeutics.com.
ITeos Therapeutics, Inc. (ITOS) Surpasses Q1 Earnings and Revenue ... - AOL
iTeos Therapeutics, Inc. , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $152.52 million for the quarter ended March 2022, surpassing the Zacks ...
Similar Companies
Loading the latest forecasts...